LABNEW (LAB) fluctuates 22.4% in 24 hours: Whale accumulation drives rebound followed by correction
Bitget Pulse2026/05/16 22:03Volatility Overview
In the past 24 hours, LABNEW (LAB) price quickly rebounded from a low of $4.23775 to a high of $5.18852, then retraced to the current $4.57115, with an overall amplitude of 22.4%. The 24-hour trading volume expanded significantly, accompanied by clear signs of net capital inflow. Market liquidity has increased but volatility remains high.
Brief Analysis of the Cause of the Move
- Whale accumulation drives rebound: On-chain monitoring shows multiple new wallets withdrawing funds from exchanges, involving about 30% of the circulating supply (approximately 100 million LAB), with an average cost near $4.9, directly pushing the price up rapidly from the bottom.
- High trading volume and capital inflow: 24-hour trading volume remains at a high level, demonstrating a surge in market participation, accompanied by net capital inflow.
- Emergence of pullback pressure: After the rebound, some profit-taking and manipulation concerns triggered selling pressure, resulting in a price retracement from the high.
Market View and Outlook
The mainstream sentiment among the community and analysts is cautiously optimistic, believing whale accumulation provides short-term support, but noting the manipulation risk associated with high volatility. It is recommended to monitor large on-chain transfers and net outflows from exchanges. Some opinions point out that the expansion of multi-chain trading terminal ecosystems (such as Monad integration) may provide long-term support, but warn of short-term profit-taking pressure.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nebius Q3 results exceed expectations, capital expenditure rises to $27 billion, ARR target postponed, stock falls over 14% pre-market | Earnings Report Insights
Nebius reported Q3 revenue of $981 million (a year-on-year increase of 571%) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company delayed and lowered its guidance for annual recurring revenue (ARR), stating that it is no longer applicable. Additionally, it significantly raised its 2026 capital expenditure target to $27 billion, with projections to further increase to $40 billion to $45 billion in 2027. The stock price plummeted more than 14% in pre-market trading.